Agonist DR5 binding polypeptides

Details for Australian Patent Application No. 2011214355 (hide)

Owner ABLYNX NV Novartis AG

Inventors Cromie, Karen; Dombrecht, Bruno; Ettenberg, Seth; Kolkman, Joost; Li, Jing; Meerschaert, Kris; Stover, David Raymond; Zhang, Jingxin

Agent Davies Collison Cave

Pub. Number AU-A-2011214355

PCT Pub. Number WO2011/098520

Priority 61/308,599 26.02.10 US; 61/303,173 10.02.10 US

Filing date 10 February 2011

Wipo publication date 18 August 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/098520 Priority application(s): WO2011/098520

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011214361-Single unit antibody purification

2011214352-Method of laying a hybrid pipeline on hte seabed